United States · FDA National Drug Code directory
MYDAYIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54092-471_13a2ab7d-af84-4e46-a58f-9e9c17b5c0e5
- Product NDC
- 54092-471
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170620
- Source listing expiry
- 20271231
Source-listed ingredients
- DEXTROAMPHETAMINE SULFATE — 6.25 mg/1
- DEXTROAMPHETAMINE SACCHARATE — 6.25 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE — 6.25 mg/1
- AMPHETAMINE SULFATE — 6.25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-471-01) · 54092-471-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →